Interaction Guide · Research summary

Can I take Glycyrrhiza Glabra with Dexamethasone?

Review Glycyrrhiza Glabra with Dexamethasone: possible adverse effects, preparation details, evidence limits, and sources.

Prepared by Dr. Edward M.Kim, PharmD · Clinical Director, SupplementSafety editorial team

Research summary published · Prepared · Editorial update

The short answer

Licorice can affect blood pressure and potassium, but it is not established that dexamethasone consistently makes those effects worse. Have the actual product reviewed; small human studies of defined constituents include contrary results.

What this answer covers

Oral dexamethasone and Glycyrrhiza glabra products. Defined glycyrrhizin and medicinal glycyrrhizinate studies are distinguished from botanical preparations.

Supplement or preparation
Glycyrrhiza glabra
Medication ingredient
dexamethasone

Which treatment this applies to

This review applies to systemic oral dexamethasone tablets. Dose, treatment duration and the condition being treated matter. It does not establish the same exposure or supplement interaction for an injection, eye preparation or skin product.

Licorice itself can affect electrolytes

Glycyrrhizin-containing licorice can raise BP and lower potassium. The regulatory assessment retains corticosteroid precautions, but explicitly notes that different steroids do not interact identically. Dexamethasone has less salt-retaining activity than some other corticosteroids.

The direct human findings are not uniformly harmful

In a small seven-day study, dexamethasone attenuated mineralocorticoid effects of isolated glycyrrhizin. A separate ITP trial of medicinal glycyrrhizinate plus dexamethasone reported improved platelet response and no severe grade 3-5 adverse events. Neither establishes that every licorice product is safe, and the available abstracts do not provide detailed long-term BP and potassium outcomes.

Use a product-specific review

Show the species, preparation, glycyrrhizin content and other ingredients to your clinician. Do not use dexamethasone to counter licorice effects yourself. New swelling, weakness, palpitations or rising BP warrant assessment; spacing the products has not been shown to remove this concern.

Evidence and practical considerations

Side effects & toxicity

The proposed added BP/potassium harm is not established for this exact pair; preparation-specific licorice precautions coexist with dexamethasone counterevidence.

Exact scope
Oral dexamethasone and Glycyrrhiza glabra products. Defined glycyrrhizin and medicinal glycyrrhizinate studies are distinguished from botanical preparations. with Exact RxNorm 3264 IN dexamethasone; plain oral tablets. Injectable phosphate and other route/formulation exposures are not treated as identical.
Medication form and route
Oral

What remains uncertain

  • Small short constituent study and indication-specific medicinal combination trial, not a controlled botanical-product safety study. Contrary findings prevent assuming uniform added potassium loss or hypertension.

Factors that may matter: Exact oral preparation and dose; Treatment duration and indication; Blood pressure and electrolyte status; Other medicines.

Research conclusion: insufficient evidence · Evidence assessment: low

Read the supporting source summaries

Source 1: Current prescribing information

dailymed.nlm.nih.gov · Source check Sep 10, 2026

Population: Patients prescribed Dexamethasone oral tablets.

Describes CYP3A4 substrate interactions, systemic bone effects and dose-dependent electrolyte precautions. Synthetic steroid salt/potassium effects are less likely except at large doses.

How this applies: Exact ingredient and specified formulation. Exact RxNorm 3264 IN dexamethasone; plain oral tablets. Injectable phosphate and other route/formulation exposures are not treated as identical.

No universal mineral requirement or same-milligram equivalence to other glucocorticoids; oral CYP effects are not automatically topical or injection effects.

Source 2: Final regulatory assessment

ema.europa.eu · Source check Sep 10, 2026

Population: Users of defined G.glabra, G.inflata or G.uralensis root/stolon preparations.

BP elevation, fluid retention and potassium loss; precaution against corticosteroid co-use that could aggravate electrolyte imbalance. Explicitly rejects assuming inhibition of every corticosteroid and notes dexamethasone counterevidence.

How this applies: Preparation-limited electrolyte/BP precaution; steroid-specific counterevidence retained.

Not an exact dexamethasone combination incidence or universal PK effect. Deglycyrrhizinated products and processed Gan cao preparations differ.

Source 3: Original clinical research

pubmed.ncbi.nlm.nih.gov · Source check Sep 10, 2026

Population: 28 healthy young adults in a randomized crossover.

Home systolic BP increased and renin/aldosterone were suppressed.

How this applies: Applicable only to the stated preparation, route and endpoints; other-drug evidence is indirect.

Abstract-only; no dexamethasone co-use or universal safe amount. Trial changes of 3.1 versus -0.3 mm Hg are not a 3.1 mm Hg between-treatment estimate.

Source 4: Original clinical research

pubmed.ncbi.nlm.nih.gov · Source check Sep 10, 2026

Population: Eighteen healthy volunteers in three groups of six.

Dexamethasone attenuated glycyrrhizin-related mineralocorticoid effects, including hypokalemia and urinary potassium loss.

How this applies: Applicable only to the stated preparation, route and endpoints; other-drug evidence is indirect.

Abstract-only; small short study with isolated glycyrrhizin, not every G.glabra product or patient. Does not justify self-treating licorice toxicity.

Source 5: Original clinical research

pubmed.ncbi.nlm.nih.gov · Source check Sep 10, 2026

Population: 111 adults randomized with newly diagnosed ITP; modified analysis included 96 treated participants.

Combination improved six-month platelet response; no grade3-5 adverse events or deaths reported.

How this applies: Applicable only to the stated preparation, route and endpoints; other-drug evidence is indirect.

Abstract-only; medicinal glycyrrhizinate, not botanical bark/root, and no detailed BP/potassium event table or dose/route in the abstract. Not proof of universal safety.

Source 6: Medication terminology

rxnav.nlm.nih.gov · Source check Sep 10, 2026

Population: Terminology.

dexamethasone is IN.

How this applies: Exact ingredient.

Not clinical evidence.

Research assessment: · Open full citations ↗

Review and change history

Publication status
Published research summary
Clinical review
Not yet recorded
DateUpdate
Article prepared
Sources checked and article drafted.
Research summary published

Article revision: 1b8c2c0674b9f0ae

This guide brings together the evidence records used by our interaction checker. Each finding retains its own preparation limits, research date, and source summaries.

Full citations require verification. Reading this answer and the source summaries does not.

Taking other supplements or medications?

Use the checker to explore your other combinations. Ask a pharmacist to review the exact products, amounts and medical conditions in your complete list.

Open the interaction checker

Information, not medical advice. Do not change prescribed treatment based on this guide.